Luminex Corp. Logo

Luminex Corp.

NASDAQ

Currency in USD
7.30
-6.80 (-48.20%)

Closed

Jul 29, 2026

Day's Range

6.92
9.09

52 wk Range

6.92
55.00
Loading

Key Statistics

Symbol

LMNX

Name

Luminex Corp.

Currency

USD

Exchange

NASDAQ

High

9.088000

Low

6.92000

Open

‪8.47‬

Last

‪7.30‬

Market Cap

667.25M

Pe Ratio

‪73.83‬

Volume

447.42K

Average Volume

86.38K

Dividend Yield

‪0.00%‬

Change

-6.80

Percent Change

-48.20

Timestamp

2026-07-29

Close

7.30500

Today Range Start

‪6.92‬

Today Range End

‪9.09‬

52 Week Range Start

‪6.92‬

52 Week Range End

‪55.00‬

Type

Stocks

Country

United States

Historical Data - LMNX - Luminex Corp.

Historical Data

TimeOpenHighLowCloseVolume

No data available

Market Cap - LMNX - Luminex Corp.

Market Cap

2026-07-28

667.25M

2026-07-27

664.27M

2026-07-24

626.16M

2026-07-23

640.27M

2026-07-22

699.37M

2026-07-21

826.59M

2026-07-20

800.90M

2026-07-17

798.88M

2026-07-16

732.75M

2026-07-15

766.95M

Earnings - LMNX - Luminex Corp.

Earnings

DateTimeEPS EstimateEPS ActualDifferenceSurprise PRC
2026-07-27-1.541.690.15‪+9.74%‬
2026-06-17-3.123.160.04‪+1.28%‬
2026-04-17-1.001.090.09‪+9.00%‬
2025-11-19-3.213.630.42‪+13.08%‬

Recommendations - LMNX - Luminex Corp.

Recommendations

DateStrong BuyBuyHoldSellStrong Sell
Jul 202600510
Jun 202600500
May 202600500
Apr 202610300

Profile - LMNX - Luminex Corp.

Profile

Mic Code

XNGS

Sector

Healthcare

Industry

Medical Instruments & Supplies

Employees

1.32K


Luminex Corp. is a biotechnology company that develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. The company's core technology platform, xMAP, enables simultaneous analysis of multiple bioassays from minimal sample volumes, utilizing microscopic polystyrene beads and advanced optical systems. Luminex offers a comprehensive portfolio including the Luminex 100/200 and FLEXMAP 3D systems for laboratory analysis, the MAGPIX multiplexing analyzer for protein and nucleic acid quantification, and the ARIES real-time PCR platform for infectious disease detection. The company provides xTAG assays for respiratory and gastrointestinal pathogen identification, along with IVD kits for cystic fibrosis genotyping and pharmacogenetic profiling. Additionally, Luminex supplies flow cytometry instruments such as Amnis imaging flow cytometers and Guava benchtop analyzers, complemented by specialized software solutions like xPONENT and SYNCT for workflow optimization. Founded in 1995 and headquartered in Austin, Texas, Luminex serves clinical diagnostic laboratories, pharmaceutical researchers, and biomedical research institutions globally, with operations across North America, Europe, and Asia.

Profile Details

Type

Common Stock

Ceo

Mr. Nachum Shamir

Address

12212 Technology Boulevard

City

Austin

State

TX

Zip

78727

Country

United States

Phone

512 219 8020

Related news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.
Luminex Corp. (LMNX - NASDAQ) Price Today | UA Finance